SPS
Study Study treatment Duration Study population Primary safety outcome measure Antiplatelet. drugs. Outcomes RE-DEEM . Dabigatran 50mg, 75mg, 110mg or 150mg bd or placebo 6 months 1861 pts with recent STEMI… ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.